1O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst,2004,96 : 1420-1425.
3Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin,2008 ,58 :71-96.
4Smith RA, Cokkinides V, Brooks D, et al. Cancer screening in the United States, 2011 : A review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin,2011,61:8-30.
5Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multi-centre randomised controlled trial. Lancet, 2010, 375 : 1624-1633.
6Zheng S, Chen K, Liu XY, et al. Cluster randomization trial of sequence mass screening for colorectal cancer. Dis Colon Rectum, 2003, 46:51-58.
7Stadlmayr A, Aigner E, Steger B, et al. Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia.J Intern Med, 2011,270 : 41-49.
8Sanderson PR, Weinstein N, Teufel-Shone N, et al. Assessing colorectal cancer screening knowledge at tribal fairs. Prey Chronic Dis,2011,8 :A16.
4Hussain SP, Harris CC. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer, 2007, 121 (11): 2373-2380.
5Uronis JM, Mtihlbauer M, Herfarth HH, et al. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS One, 2009, 4 (6): e6026.
6Lukas M. Inflammatory bowel disease as a risk factor for colorectal cancer. Dig Dis, 2010, 28 (4-5): 619-624.
7Roncucci L, Mora E, Mariani F, et al. Myeloperoxidasepositive cell infiltration in colorectal carcinogenesis as indicator of colorectal cancer risk. Cancer Epidemiol Biomarkers Prey, 2008, 17 (9): 2291-2297.
8Rindi G, Leiter AB, Kopin AS, et al. The 'normal' endocrine cell of the gut: changing concepts and new evidences. Ann N Y Acad Sci, 2004, 1014: 1-12.
9Lomax AE, Linden DR, Mawe GM, et al. Effects of gastrointestinal inflammation on enteroendocrine cells and enteric neural reflex circuits. Auton Neurosci, 2006, 126-127: 250-257.
10Haub S, Ritze Y, Bergheim I, et al. Enhancement of intestinal inflammation in mice lacking interleukin 10 by deletion of the serotonin reuptake transporter. Neurogastroenterol Motil, 2010, 22 (7): 826-834, e229.
